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Abstract
Background Internationally, there have been efforts to adjust hospital funding based on the quality of care
provided by the hospital. A variety of approaches has been used by different countries and payers.
Incorporating quality signals into activity-based funding is also a possibility for Australia. This study set out to
explore the cost impact of potentially poor quality care in Australian hospitals, and to understand the
implications from a funding perspective.
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Background
Internationally, there have been efforts to adjust hospital
funding based on the quality of care provided by the
hospital. A variety of approaches has been used by dif-
ferent countries and payers. Incorporating quality signals
into activity-based funding is also a possibility for
Australia.
This study set out to explore the cost impact of poten-
tially poor quality care in Australian hospitals, and to
understand the implications from a funding perspective.
Materials and methods
Since 2008, Australia has incorporated into its routinely
collected hospital data a flag to indicate whether each
diagnosis was pre-existing at the time of admission, or if
it arose during the hospital stay (i.e., a hospital-acquired
condition). This is known as the Condition Onset Flag
(COF).
This study used the Admitted Patient Care National
Minimum Data Set (NMDS) and the National Hospital
Cost Data Collection for 2011-2012. These are routine
national collections of admitted patient data, and activity-
based costing data, respectively.
The analysis of the cost impact was limited to medium
and large hospitals (i.e. facilities with approximately
2,000 or more separations annually, using the national
peer group classification). Within these peer groups, the
analysis included only hospitals that coded the COF. The
analysis was further restricted to acute episodes of
admitted patient care (for example, excluding rehabilita-
tion and palliative care episodes), and a set of Australian
Refined Diagnostic Related Groups (AR-DRGs) identified
by the Australian Commission on Safety and Quality in
Health Care (based on volume, cost, and priority areas
for quality and safety initiatives). Just over 400,000 epi-
sodes were included in the detailed analysis.
The primary analysis was based on a Generalized Lin-
ear Model in which differences in cost or length of stay
were modeled using the presence of hospital acquired
conditions as explanatory variables, together with a
range of control variables (including age, emergency
care status, and the presence of other comorbidities).
Alternative specifications for the presence of hospital-
acquired conditions were estimated, using the Classifica-
tion of Hospital Acquired Conditions (CHADx) [1].
Models were estimates for each adjacent AR-DRG.
Results
An estimate was made of the total incremental impact of
the presence of hospital-acquired conditions, both within
the sample, and scaling it to reflect all acute episodes
allocated to the selected conditions and/or interventions
(mapped to Adjacent DRGs) in the selected public and
private hospitals.
Across the sample of conditions and/or interventions
identified by the Commission, the mean incremental
impact of the presence of any COF diagnosis was esti-
mated to be 9,244 AUD (with a median of 6,710 AUD).
Scaled to all acute episodes, hospital-acquired conditions
accounted for between 12% and 16.5% of total costs within
the sample, and between 11.6% and 15.9% of costs across
all hospitals for the selected conditions. Across all acute
episodes assigned to Adjacent DRGs of the selected condi-
tions, the incremental cost of hospital-acquired conditions
was estimated to be between 634 million and 896 million
AUD. To place this estimate in context, total expenditures
for public hospitals were 40,384 million AUD in 2011-
2012, of which approximately 28,000 million AUD (70%)
was related to admitted patients.
The highest costs were associated with less costly (per
case) but more frequent complications. Total cost
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impacts of these conditions ranged from 10.9 million
AUD for pressure ulcers (1,866 episodes) to 27.4 million
AUD for electrolyte disorders without dehydration
(9,808 episodes).
Conclusions
This study’s estimate of the cost impact of hospital
acquired diagnoses offers insights into costs that could
be shifted, if incorporating quality signals into activity-
based funding reduced these complications.
Four broad options for how quality signals might be
incorporated into funding are:
1. Maintain the current core activity-based funding
approach and create a separate funding / payment
stream related to performance against quality-related
measures / benchmarks, including those based on analy-
sis of hospital acquired conditions.
2. Exclude all hospital-acquired complications when
assigning DRGs, so the presence of such a diagnosis
does not impact the patient’s DRG (and the facilities’
subsequent funding).
3. Exclude a subset of hospital-acquired complications
in the AR-DRG assignment.
4. Exclude the costs of hospital-acquired complications
in calculating the price weights for each DRG.
While not all hospital-acquired conditions can be pre-
vented with current medical knowledge, incorporating
quality signals into pricing might motivate greater
efforts to reduce them, where possible.
The limitations of the study should be noted. We found
coding of the COF to vary between hospitals and states.
The study is vulnerable to endogeneity bias because of the
circular relationship between length of stay and rates of
hospital-acquired harms. Length of stay may be extended
by complications that arise during the admission, but
longer stays also expose patients to a higher probability
that a hospital-acquired condition will occur. Both are
highly correlated with higher costs.
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